Transient antibody targeting of CD45RC inhibits the development of graft-versus-host disease

Allogeneic bone marrow transplantation (BMT) is a widely spread treatment of many hematological diseases, but its most important side effect is graft-versus-host disease (GVHD). Despite the development of new therapies, acute GVHD (aGVHD) occurs in 30% to 50% of allogeneic BMT and is characterized b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Blood Adv
Autores principales: Boucault, Laetitia, Lopez Robles, Maria-Dolores, Thiolat, Allan, Bézie, Séverine, Schmueck-Henneresse, Michael, Braudeau, Cécile, Vimond, Nadège, Freuchet, Antoine, Autrusseau, Elodie, Charlotte, Frédéric, Redjoul, Rabah, Beckerich, Florence, Leclerc, Mathieu, Piaggio, Eliane, Josien, Regis, Volk, Hans-Dieter, Maury, Sébastien, Cohen, José L., Anegon, Ignacio, Guillonneau, Carole
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2020
Materias:
Transplantation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7284095/
https://ncbi.nlm.nih.gov/pubmed/32511714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001688
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares